Do-Coop Technologies Ltd. is a private company based in Israel. Do-Coop was formed in 1997 in order to develop and commercialize novel water-based materials using water-based nanotechnology for the biotechnology, pharmaceutical, and chemical industries. The Company has spent over seven years developing and optimizing its first line of products, branded as Neowater™. Do-Coop has recently started commercialization of its first line of Neowater™-based products targeting the molecular diagnostics and research market within the Life Sciences industry, and is now offering the new solubilization service to Pharma and Biotech companies to enhance bioavailability and solubility of existing and new drugs.

Neowater can be used in pharmaceuticals and laboratory assays to boost the performance of a drug or diagnostic test. Neowater is nontoxic, environmentally friendly, and can easily be integrated into already existing drugs and diagnostic testing products and allow for IPR extension of such. Since Neowater is made of water, its value as a replacement for organic solvents is significant and unique to the Biotech and Pharma industries.Do-Coop has used Neowater technology to develop several generic products with pharmaceutical and research applications, including solubility enhancers, enzyme activity and stability enhancers, and cellular uptake enhancers such as transfection enhancers. Several Neowater-based products and services are commercially available.